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ABSTRACT: The article highlights their therapeutic role of svasa kuthara rasa and sirishadi 
kashaya in the management of bronchial asthma. 
 
Introduction: 
 
Tamaka  svasa  (Bronchial  asthma)  is 
prevalent  in  most  parts  of  India.  With  the 
increasing population and mental stress the 
disease  is  imposing  burden  on  the 
community  of  developing  countries  like 
India,  It  has  been  observed  that 
immunological  structural  functional 
microbiological changes occurring inhuman 
body  can  be  closely  related  with  the 
epidemiological environmental occupational 
personal  or  social  factors  which  makes  a 
man prone to develop this disease. 
 
Modern  medicine  is  much  advanced  in 
treating  the  infectious  diseases  but  has 
limitations in treating diseases like asthma, 
diabetes  mellitus  etc.,  and  provides  only 
palliative  treatment.  In  treatment  of 
bronchial  asthma  extensive  use  of 
bronchodilators,  antibiotics  steroids  and 
other  measures  are  helpful  to  some  extent 
but  to  eradicate  it  and  to  give  permanent 
cure  of  this  disease  is  still  beyond  their 
capacity.  Prolonged  use  of  steroid  therapy 
may cause suppression of immune response, 
hypertension  diabetes  mellitus  etc.  On  the 
other  hand  in  Ayurveda  the  proper 
implementation  of  ancient,  approach  is 
advantageous. 
 
Svasakutharasa  is  widely  prescribed  by 
Ayurvedic physicians since long till today. 
As  Ayurvedic  texts  shows  that  this 
formulation is indicated for svasa, Kasa and 
other  diseases  like  vishama  jwara, 
pratishyaya, rajayakshma etc. 
 
Shirishadi  Kashaya  is  an  important 
formulation of Ayurveda and is found anti-
allergic  by  so  many  workers.  Its  positive 
effects  in  Tamaka  shvasa  are  believed  by 
ayurvedic scientists. 
 
Keeping  this  idea  in  mind  a  comparative 
study has been done to assess the effect of 
svasa kuthara rasa and shirishadi kashaya in 
the patients of Tamaka svasa. 
 
Material and Methods: 
 
Selection of the patients: 
 
30 patients attending to Kaya chikitsa OPD 
of,  S.S  Hospital  BHU,  with  the  chief 
complains  of  paroxysmal  attacks  of 
breathlessness, having prolonged expiration 
time,  rhonchi  and  rales  with  or  without 
history of allergy were selected for clinical 
trial  .Out  of  them  those  having 
complications  like  emphysema, 
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more  than  2000/cu.mm,  having  positive 
ECG findings and radiographic evidences of 
Koch’s have been excluded from the trial. 
 
Selection of the Drugs: 
 
Svasa  Kuthararasa  is  a  classical 
herbomineral  preparation.  It  contains 
purified rasa (Mercury), purified Gandhaka 
(Sulphur) purified tankana (Borax) purified 
manahshila  (Realgar)  purified  vatsanabha 
(Aconite) along with trikatu. Its methods of 
preparation  and  indications  are  clearly 
mentioned  in  bhaishajya  ratnawali  (Hikka-
Svasa  Chikitsa  16/46-50)  and  yoga 
Ratnakar. 
 
Shirishadi  Kashaya,  an  excellent  herbal 
preparation  was  formulated  by  Late  Prof. 
S.N  Tripathi  from  his  experience  of 
treatment,  the  constituents  of  the  said 
kashaya  are  shirisha  (Albizzia  lebbeck), 
Vasa  (Adhatoda  vasica),  Kantakari 
(Solanum xanthocarpum) and Yashtimadhu 
(Glycyrhiza glabra). These four drugs have 
been  established  as  the  effective  drug  of 
choice  in  svasa,  Kasa  and  other  allergic 
disorders. 
 
Administration of Drugs: 
 
The  30  patients  selected  for  trial  were 
randomly put into 2 groups 
A-Svasa Kuthararasa group 
B-Shirishadi kashaya group 
In both groups 15-15 patients were selected. 
In  group  A-Svasakuthara  rasa  was 
administered  in  the  dose  of  250mg  (1cup) 
two  times  a  day  with  boiled  and  cooled 
water, for a period of 45 days and response 
was assessed at the interval of 15 days up to 
3 subsequent visits. 
 
In group B- Shirishadi Kashaya was given in 
the  dose  of  25ml  two  times  a  day  for  a 
period of 45 days. 
 
Diet: 
 
All  the  patients  were  kept  on  normal  diet 
with  the  avoidance  of  cold  substances 
specially curd, cold drinks etc. A part from 
diet they were also advised not to expose to 
cold  climate  smoke  an  dusty  environment. 
All  the  patients  were  followed  up  at  the 
interval of 15 days. 
 
Parameters  for  assessment  of  the 
response of trial drugs: 
 
To  evaluate  the  therapeutic  response  of 
drugs  the  following  parameters  have  been 
adopted  
 
a) Subjective  
b) Objective 
 
a)  Subjective  Parameters:  Under  this 
criteria  dyspnoea,  cough,  days  of 
asthma  per  week,  frequency  of 
asthmatic  attacks were noted before 
and  after  treatment.  The  dyspnoea 
and  cough  has  been  recorded  in 
grades  on  the  basis  of  tolerance  of 
work and exercise and frequency in 
24  hours  respectively.  Likewise 
dyspnoea  and  cough  the  days  of 
asthmatic attacks per week frequency 
of  asthmatic  attacks  were  recorded 
and  numerical  scoring  was  done 
according to good et al (1971). 
 
b)  Objective  Parameters:  Under  this 
criteria only vital capacity has been 
measured  in  all  patients  before 
treatment and the interval of 15 days 
for up to 3 subsequent visits. 
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1.  Effect of treatment of dyspnoea (Table No 1) 
Group –A-Svasa Kuthararasa group (N=15) 
 
 
  BT  AT1 
(15 days)  d1  AT2 
(30 days)  d2  AT3 
(45 days)  d3 
MGS 
SD(±) 
SE 
t 
p 
2.33 
1.175 
0.303 
2.0 
1.195 
0.308 
0.33 
0.723 
0.186 
1.792 
>0.05 
2.007 
1.162 
0.300 
0.267 
0.798 
0.206 
1.31 
>0.05 
2.13 
0.99 
0.255 
0.2 
0.774 
0.200 
1.0 
>0.05 
 
As  evident  from  table  no.1  although  the 
relief in  dyspnoea  was  observed in  all the 
patients  of  svasa  kuthara  rasa  group  on 
statical analysis it was not significant at all 
levels  (P>0.05).    While  in  group  B  the 
patients were treated with shrishadi kashaya 
alone. The relief in dyspnoea was significant 
on 15
th day (P<0.05) and highly significant 
on 30 and 45 days of treatment (P<0.01 and 
<0.001). 
 
On  comparison  the  effect  of  Shirishati 
kashaya on dyspnoea was found to be better 
than that svasa kuthara rasa alone. 
 
Group –B-Shirishadi Kashaya group (N=15) 
 
 
  BT  AT1 
(15 days) 
d1  AT2 
(30 days) 
d2  AT3 
(45 days) 
d3 
MGS 
SD(±) 
SE 
t 
p 
2.20 
1.207 
0.311 
1.86 
1.060 
0.273 
0.34 
0.487 
0.126 
2.698 
<0.05 
1.73 
1.032 
0.266 
0.470 
0.515 
0.133 
3.508 
<0.01 
1.34 
0.816 
0.210 
0.86 
0.639 
0.165 
5.252 
<0.001 
2.   
2.  Effect of treatment of dyspnoea (Table No 2) 
Group –A-Svasa Kuthararasa group (N=15) 
 
  BT  AT1 
(15 days) 
d1  AT2 
(30 days) 
d2  AT3 
(45 days) 
d3 
MGS 
SD(±) 
SE 
t 
p 
2.13 
0.833 
0.215 
1.86 
1.125 
0.290 
0.27 
0.703 
0.181 
1.492 
>0.05 
1.8 
1.207 
0.311 
0.33 
0.816 
0.210 
1.587 
>0.05 
1.73 
0.798 
0.206 
0.4 
0.632 
0.163 
2.452 
<0.05 
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  BT  AT1 
(15 days) 
d1  AT2 
(30 days) 
d2  AT3 
(45 days) 
d3 
MGS 
SD(±) 
SE 
t 
p 
2.0 
0.961 
0.248 
1.66 
0.723 
1.186 
0.34 
0.507 
0.130 
2.62 
<0.01 
1.26 
0.593 
0.153 
0.74 
0.676 
0.174 
4.25 
<0.001 
1.333 
0.351 
0.090 
0.87 
0.798 
0.206 
4.21 
<0.001 
 
Table No.2 reveals that in group A the improvement in cough by Shavasa Kuthararasa was 
statically significant only on 45 the days of treatment while in group B the improvement in 
cough was highly significant at all levels (P<0.01 and <.001). 
 
3.  Effect of treatment on days of asthma per week (Table No 3) 
Group –A-Svasa Kuthararasa group (N=15) 
 
  BT  AT1 
(15 days) 
d1  AT2 
(30 days) 
d2  AT3 
(45 days) 
d3 
MGS 
SD(±) 
SE 
t 
p 
4.00 
1.812 
0.468 
3.85 
1.698 
0.438 
0.16 
0.414 
0.106 
1.51 
>0.05 
3.73 
1.791 
0.462 
0.27 
0.703 
0.181 
1.491 
>0.05 
3.66 
1.877 
0.484 
0.34 
0.723 
0.186 
1.827 
>0.05 
 
Group –B-Shirishadi Kashaya group (N=15) 
 
  BT  AT1 
(15 days) 
d1  AT2 
(30 days) 
d2  AT3 
(45 days) 
d3 
MGS 
SD(±) 
SE 
t 
p 
4.26 
1.767 
0.430 
3.86 
1.552 
0.400 
0.4 
0.985 
0.254 
1.574 
>0.05 
3.66 
1.447 
0.373 
0.6 
0.988 
0.254 
2.362 
<0.05 
3.6 
1.764 
0.455 
0.06 
0.617 
0.159 
4.192 
<0.01 
 
On statistical analysis the mean difference was not significant on all levels (P>0.05)in group A. 
In group B the reduction in the mean score was highly significant on 30th and 45
th days of 
treatment (P<0.05) 
 
4.  Effect of treatment on frequency of asthmatic attacks per week (Table No 4) 
Group –A-Svasa Kuthararasa group (N=15) 
 
  BT  AT1 
(15 days) 
d1  AT2 
(30 days) 
d2  AT3 
(45 days) 
d3 
MGS 
SD(±) 
4.66 
1.877 
4.46 
1.846 
0.20 
0.560 
4.33 
2.319 
0.33 
0.816 
4.26 
0.560 
0.40 
0.828 
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t 
p 
0.454  4.476  0.144 
1.388 
>0.05 
0.599  0.210 
1.587 
>0.05 
0.462  0.213 
1.877 
>0.05 
 
Group –B-Shirishadi Kashaya group (N=15) 
 
  BT  AT1 
(15 days) 
d1  AT2 
(30 days) 
d2  AT3 
(45 days) 
d3 
MGS 
SD(±) 
SE 
t 
p 
5.0 
2.0 
0.516 
4.733 
2.086 
0.538 
0.26 
0.547 
0.118 
2.262 
<0.05 
4.466 
1.995 
0.515 
0.534 
0.833 
0.215 
2.480 
<0.05 
4.33 
2.093 
0.540 
0.607 
0.816 
0.210 
3.19 
<0.01 
 
As evident from table no 4 the reduction in means score of frequency of asthmatic attacks per 
week was statistically not significant in group A (P>0.05). On the other hand in group B treated 
with shirishadi kashaya the reduction in frequency of asthmatic attacks  per week was much 
better and significant (P<0.05 and <0.01). 
 
5.  Effect of treatment on vital capacity (Table No 5) 
Group –A-Svasa Kuthararasa group (N=15) 
 
  BT  AT1 
(15 days) 
d1  AT2 
(30 days) 
d2  AT3 
(45 days) 
d3 
MGS 
SD(±) 
SE 
t 
p 
2340cc 
356.17 
91.986 
2360cc 
355.51 
86.652 
20.0 
41.403 
0.693 
1.870 
>0.05 
2366.66cc 
324.404 
83.782 
26.66 
59.361 
15.331 
1.739 
>0.05 
2380cc 
321.158 
82.943 
40.00 
73.678 
19.028 
2.102 
>0.05 
 
Group –B-Shirishadi Kashaya group (N=15) 
 
  BT  AT1 
(15 days) 
d1  AT2 
(30 days) 
d2  AT3 
(45 days) 
d3 
MGS 
SD(±) 
SE 
t 
p 
2340cc 
392.42 
101.35 
2386.66cc 
390.725 
100.91 
46.66 
63.994 
16.527 
2.823 
<0.02 
2393.33cc 
397.252 
102.596 
53.33 
51.639 
13.336 
3.999 
<0.01 
2413.33cc 
410.342 
105.976 
73.33 
45.773 
11.82 
6.203 
<0.01 
 
In group A the slight improvement in vital capacity was observed but on statical analysis it was 
not significant (p>0.05). On the other hand in group B the improvement in vital capacity was 
significant (P<0.1 and <0.001). 
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Tamaka Svasa like any other psychosomatic 
ailment is a disease of multiple aetiology in 
such  type  of  diseases  the  problem  is 
complex and is likely to disease the problem 
is  complex  and  is  likely  to  deviate  from 
place to place and society to society. There 
are several factors namely allergy, infection 
endocrine,  psychic  and  hereditary,  which 
play  pivotal  role  in  the  causation  of  this 
disease.  There  may  be  cases  having  more 
than one factor in operation simultaneously 
or one may follow the other, considering all 
these factors no two cases of Tamaka svasa 
can identical in all aspects. 
 
In addition the evaluation of response of a 
drug  becomes  further  difficult  due  to  self 
limiting nature of the disease. Under these 
circumstances an individuals can make only 
a  humble  attempt  of  clinical  trial  giving 
some voluble information of primary nature. 
 
Hence  it  is  concluded  that  shririshadi 
Kashaya has significant effect on dyspnoea 
and cough (P<0.01), significant reduction in 
mean  days  of  asthma  per  week  (P<0.05). 
There  was  highly  significant  rise  in  vital 
capacity observed (P<0.001). 
 
Regarding the effect of svasa kuthara rasa, 
similar  to  shirishadi  kashaya  its  effect  on 
dyspnoea cough, days of asthma per week 
frequency of asthmatic attacks per week and 
vital capacity were also observed but it was 
found  not  to  be  so  effective  as  shirishadi 
kashaya in the treatment of Tamaka svasa. 
 
Since  it  was  a  time  bound  programme  to 
evaluate the effect of said drugs, it requires 
further  double  blind  trial  to  confirm  the 
observations and results reported herewith , 
it is hoped that the work presented there will 
be  beneficial  to  other  research  workers 
willing to take up the work in this field. 
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d1  - Mean difference between BT- AT1 
d2  - Mean difference between BT- AT2 
d3  - Mean difference between BT- AT3 
MGS  - Mean Grade Score. 
SE  - Standard Error. 
 
REFERENCES 
 
Bhaishajya  Ratnawali:  Kaviraj  Shree  Ambika  Dutta  Shastri,  Chaukhambha  Sanskrit  Series, 
Varanasi, 1981. 
 
Yoga Ratnakar: Hindi Commentary by Laxmipati shastri IInd ed. Chawkhamba Sanskrit series, 
Varanasi, 1973. 
 
Medicinal Plants of India: Satyavati G.V & Gupta A.K ,Vol 2,1987, I.C.M.R, New Delhi. 
 
Pages 213 - 218Davidson’s  practice  and:  Principles  of  medicine  16
th  edition  1991,  E.L.B.S.  Churchil 
Livingstone. 
 
Graham K. Crompton: Diagnosis and management of Respiratory Diseases ed 2
nd, 1987, Black 
well Scientific Publications. 
 
Shukla Pratiba tripathi S.N et al, (1980): Immuno suppressive and antihistamimic effect of A. 
lebbeck (Shirisha) with special reference to bronchial asthma, conference on the role of Ay. and 
Trad. Med in P.H.S., IMS, BHU. 
 
Tripathi  Pratibha,  tripathi  Y.B.,  and  Tripathi  S.N  (1983):  Steroidogenic  effect  of  A  lebbeck 
Benth in guinea Pigs, Ancient science of Life, Vol 2 No III. 
 
David  M.  Mitchell:  Recent  Advances  in  Respiratory  Medicine  No.5,  (1991),  Churchil 
Livingstone, London, U.K. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
  
 
Pages 213 - 218 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Pages 213 - 218